Dave is the Principal Beamline Scientist on the small-molecule single-crystal diffraction beamline, I19. Before his appointment at Diamond in 2006, Dave was a lecturer in The School of Physics at The University of Edinburgh and he laterally held an EPSRC Advanced Research Fellowship within The School of Chemistry. Apart from developing the beamline to improve its capabilities for the ever increasing user base, his main research interests involve the high-pressure and low-temperature polymorphism of small-molecule systems and the development of in situ crystal growth techniques. Dave can occasionally been seen around the department, usually on Tuesdays, when he gets the chance to attend the Chem. Cryst. group meetings.
Chiralabs are long-term collaborators and world-leading experts in a wide range of spectroscopic, physicochemical and theoretical approaches including in chirality, circular dichroism, optical spectroscopies, crystallization and biopharmaceutical analysis. Specialist areas of investigation include:
- Molecular chirality & enantiomeric composition
- Crystal growth, polymorphism & solubility
- Biomacromolecular structure, folding and properties
- Biopharmaceutical development & spectroscopic fingerprinting
- Spectroscopic & physicochemical characterisation
Chiralabs is also the home of CrystalGEM, the internationally award winning rational crystallisation screening technology that has revolutionised the screening of pharmaceutical polymorphism, morphology and crystal growth.
Francesco obtained his PhD in Rome and since 2004 is Assistant Professor at the Chemical Division of the Department of Pharmaceutical Science of the University of Catania, Italy. He spent some months during 2005 and 2006 in our lab to improve his knowledge of crystallography. His principal area of research is the comparison of experimental X-ray diffraction data with computationally simulated data. The prediction of crystal morphology, polymorphism, atomic displacement parameters (adp), as well as the physico-chemical properties of biologically active compounds are among his interests.